同济堂
  Investor Relations
   Directors and Executive Officers
   Corporate Governance
    Stock Information
   Financials Reports
   SEC Filings
   Events
   Analyst Coverage
   IR Contact
 
  Investor Relations You are here: Home -- Investor Relations  
 
  Corporate Profile
Tongjitang Chinese Medicines Company is a vertically integrated and profitable specialty pharmaceutical company focusing on the development, manufacturing,marketing and selling of modernized traditional Chinese medicine in China. ...More>>
 
Exchange: NYSE (US Dollar)
Price: 3.68
Change: 0.07
Volume: 28770
Data as of: 9/4/2008 4:00pm
 
 
 
 
  Aug 15,2008 Tongjitang Chinese Medicines Company Announces Second Quarte......
 
 
  Aug 15,2008 Tongjitang Chinese Medicines Company Announces CFO and Direc......
 
 
  Aug 13,2008 Tongjitang Chinese Medicines Company to Announce Second Quar......
 
     
 
Date Format Title
Jan 28, 2008 Printer Friendly Version Presentation - Investor Conference January 2008
 
IR Contact
f
Ashley Ammon MacFarlane
ICR
Tel:1-203-682-8200
Email:ashley.macfarlane@icrinc.com